User login
Article Type
Changed
Fri, 01/04/2019 - 11:11
Display Headline
Cardiovascular disease in oncology
In the first quarter of 2015, a number of papers that addressed cardiovascular issues in oncology were published. These included studies of the cardiovascular toxicity of cancer therapy, treatment guidelines from the American Society of Clinical Oncology (ASCO) for venous thromboembolism prophylaxis (VTE), and the prognostic significance of superficial vein thrombosis.
Click on the PDF icon at the top of this introduction to read the full article.
Article PDF
Issue
The Journal of Community and Supportive Oncology - 13(6)
Page Number
231-234
Legacy Keywords
cardiovascular disease, CVD, cardiovascular toxicity, venous thromboembolism, VTE, superficial vein thrombosis, SVT, prostate cancer, cerebral microbleeds, CMBs, whitematter lesions, WMLs, vascular adverse events, VAEs, nilotinib, ponatinib, bosutinib, dasatinib
Sections
Article PDF
Article PDF
In the first quarter of 2015, a number of papers that addressed cardiovascular issues in oncology were published. These included studies of the cardiovascular toxicity of cancer therapy, treatment guidelines from the American Society of Clinical Oncology (ASCO) for venous thromboembolism prophylaxis (VTE), and the prognostic significance of superficial vein thrombosis.
Click on the PDF icon at the top of this introduction to read the full article.
In the first quarter of 2015, a number of papers that addressed cardiovascular issues in oncology were published. These included studies of the cardiovascular toxicity of cancer therapy, treatment guidelines from the American Society of Clinical Oncology (ASCO) for venous thromboembolism prophylaxis (VTE), and the prognostic significance of superficial vein thrombosis.
Click on the PDF icon at the top of this introduction to read the full article.
Issue
The Journal of Community and Supportive Oncology - 13(6)
Issue
The Journal of Community and Supportive Oncology - 13(6)
Page Number
231-234
Page Number
231-234
Article Type
Display Headline
Cardiovascular disease in oncology
Display Headline
Cardiovascular disease in oncology
Legacy Keywords
cardiovascular disease, CVD, cardiovascular toxicity, venous thromboembolism, VTE, superficial vein thrombosis, SVT, prostate cancer, cerebral microbleeds, CMBs, whitematter lesions, WMLs, vascular adverse events, VAEs, nilotinib, ponatinib, bosutinib, dasatinib
Legacy Keywords
cardiovascular disease, CVD, cardiovascular toxicity, venous thromboembolism, VTE, superficial vein thrombosis, SVT, prostate cancer, cerebral microbleeds, CMBs, whitematter lesions, WMLs, vascular adverse events, VAEs, nilotinib, ponatinib, bosutinib, dasatinib
Sections
Citation Override
JCSO 2015;13:231-234
Disallow All Ads
Alternative CME
Article PDF Media
Document